Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001096906-09-000282
Filing Date
2009-03-31
Accepted
2009-03-31 09:45:39
Documents
5
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 TETRAGENEX PHARMACEUTIRCALS, INC. FORM 10-K DECEMBER 31, 2008 tetragenex10k123108.htm 10-K 1166169
2 CERTIFICATION OF CO-CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBA tetragenex10k123108ex31-1.htm EX-31.1 15745
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES tetragenex10k123108ex31-2.htm EX-31.2 15746
4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION tetragenex10k123108ex32-1.htm EX-32.1 11832
5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION tetragenex10k123108ex32-2.htm EX-32.2 12363
  Complete submission text file 0001096906-09-000282.txt   1223268
Mailing Address 1 MAYNARD DRIVE, SUITE 205 PARK RIDGE NJ 07656
Business Address 1 MAYNARD DRIVE, SUITE 205 PARK RIDGE NJ 07656 (201) 505-1300
TETRAGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0001362659 (see all company filings)

EIN.: 223781895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52292 | Film No.: 09716251
SIC: 2834 Pharmaceutical Preparations